Gabexate mesilate in human acute pancreatitis
- 1 April 1993
- journal article
- clinical trial
- Published by Elsevier in Gastroenterology
- Vol. 104 (4), 1165-1170
- https://doi.org/10.1016/0016-5085(93)90288-n
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Multicenter Double-Blind Trial of Gabexate Mesylate (FOY) in Unselected Patients with Acute PancreatitisDigestion, 1992
- Apical secretion of lysosomal enzymes in rabbit pancreas occurs via a secretagogue regulated pathway and is increased after pancreatic duct obstruction.Journal of Clinical Investigation, 1991
- Inhibition of porcine pancreas phospholipase A2 activation by gabexate mesilateKlinische Wochenschrift, 1989
- In vitro inhibition of phospholipase A2 by gabexate mesilate, camostate, and aprotinineKlinische Wochenschrift, 1989
- Controlled Trial of Protease Inhibitor Gabexelate Mesilate (FOY) in the Treatment of Acute PancreatitisPancreas, 1987
- Gabexate Mesilate (FOY) Protects Against Ceruletide-Induced Acute Pancreatitis in the RatPancreas, 1987
- PancreatitisDigestive Diseases and Sciences, 1984
- Effect of a Specific Serine Protease Inhibitor on the Rat Pancreas: Systemic Administration of Camostate and Exocrine Pancreatic SecretionDigestion, 1984
- Treatment of Acute Pancreatitis with SomatostatinNew England Journal of Medicine, 1980
- A Double-blind Trial of Synthetic Salmon Calcitonin in the Treatment of Acute PancreatitisScandinavian Journal of Gastroenterology, 1979